Loading...

Vascular Biogenics Ltd.

VBLT•NASDAQ
Healthcare
Biotechnology
$0.16
$-0.02(-8.77%)
U.S. Market opens in 6h 37m

Vascular Biogenics Ltd. (VBLT) Stock Overview

Explore Vascular Biogenics Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.1M
P/E Ratio-0.38
EPS (TTM)$-0.18
ROE-0.86%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

VBLT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Vascular Biogenics Ltd. (VBLT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.38 and a market capitalization of 12.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-8.77%
3-Month Change
-33.62%
6-Month Change
-22.00%
Year-to-Date (YTD) Change
15.64%
1-Year Change
19.72%
3-Year Change
-86.78%
5-Year Change
-86.32%
All-Time (Max) Change
-98.48%

Contact Information

https://www.vblrx.com
972 8 993 5000
8 HaSatat Street, Hevel Modi'in, NaN, 7178106

Company Facts

70 Employees
IPO DateOct 1, 2014
CountryIL

Frequently Asked Questions